CLN5

CLN5

Ceroid-lipofuscinosis, neuronal 5, also known as CLN5, is a human gene.cite web | title = Entrez Gene: CLN5 ceroid-lipofuscinosis, neuronal 5| url = http://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=1203| accessdate = ]

PBB_Summary
section_title =
summary_text = The neuronal ceroid lipofuscinoses (CLN or NCL) are a group of autosomal recessive, progressive encephalopathies in children. They are characterized by psychomotor deterioration, visual failure, and the accumulation of autofluorescent lipopigment in neurons and other cell types. The main childhood forms are the infantile type (Santavuori-Haltia disease; MIM 256730), the late infantile type (Jansky-Bielschowsky disease; MIM 204500), and the juvenile type (Batten disease; MIM 204200) based on the age of onset, clinical course, neurologic and ophthalmologic findings, and ultrastructural analysis (Carpenter et al., 1977 [PubMed 193610] ). [supplied by OMIM] cite web | title = Entrez Gene: CLN5 ceroid-lipofuscinosis, neuronal 5| url = http://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=1203| accessdate = ]

References

Further reading

PBB_Further_reading
citations =
*cite journal | author=Mole SE, Mitchison HM, Munroe PB |title=Molecular basis of the neuronal ceroid lipofuscinoses: mutations in CLN1, CLN2, CLN3, and CLN5. |journal=Hum. Mutat. |volume=14 |issue= 3 |pages= 199–215 |year= 1999 |pmid= 10477428 |doi= 10.1002/(SICI)1098-1004(1999)14:3<199::AID-HUMU3>3.0.CO;2-A |doilabel=10.1002/(SICI)1098-1004(1999)14:3199::AID-HUMU33.0.CO;2-A
*cite journal | author=Dawson G, Cho S |title=Batten's disease: clues to neuronal protein catabolism in lysosomes. |journal=J. Neurosci. Res. |volume=60 |issue= 2 |pages= 133–40 |year= 2000 |pmid= 10740217 |doi=
*cite journal | author=Vesa J, Peltonen L |title=Mutated genes in juvenile and variant late infantile neuronal ceroid lipofuscinoses encode lysosomal proteins. |journal=Curr. Mol. Med. |volume=2 |issue= 5 |pages= 439–44 |year= 2003 |pmid= 12125809 |doi=
*cite journal | author=Mole SE |title=The genetic spectrum of human neuronal ceroid-lipofuscinoses. |journal=Brain Pathol. |volume=14 |issue= 1 |pages= 70–6 |year= 2004 |pmid= 14997939 |doi=
*cite journal | author=Carpenter S, Karpati G, Andermann F, "et al." |title=The ultrastructural characteristics of the abnormal cytosomes in Batten-Kufs' disease. |journal=Brain |volume=100 Pt 1 |issue= |pages= 137–56 |year= 1977 |pmid= 193610 |doi=
*cite journal | author=Savukoski M, Kestilä M, Williams R, "et al." |title=Defined chromosomal assignment of CLN5 demonstrates that at least four genetic loci are involved in the pathogenesis of human ceroid lipofuscinoses. |journal=Am. J. Hum. Genet. |volume=55 |issue= 4 |pages= 695–701 |year= 1994 |pmid= 7942847 |doi=
*cite journal | author=Klockars T, Savukoski M, Isosomppi J, "et al." |title=Efficient construction of a physical map by fiber-FISH of the CLN5 region: refined assignment and long-range contig covering the critical region on 13q22. |journal=Genomics |volume=35 |issue= 1 |pages= 71–8 |year= 1996 |pmid= 8661106 |doi= 10.1006/geno.1996.0324
*cite journal | author=Savukoski M, Klockars T, Holmberg V, "et al." |title=CLN5, a novel gene encoding a putative transmembrane protein mutated in Finnish variant late infantile neuronal ceroid lipofuscinosis. |journal=Nat. Genet. |volume=19 |issue= 3 |pages= 286–8 |year= 1998 |pmid= 9662406 |doi= 10.1038/975
*cite journal | author=Heinonen O, Salonen T, Jalanko A, "et al." |title=CLN-1 and CLN-5, genes for infantile and variant late infantile neuronal ceroid lipofuscinoses, are expressed in the embryonic human brain. |journal=J. Comp. Neurol. |volume=426 |issue= 3 |pages= 406–12 |year= 2000 |pmid= 10992246 |doi=
*cite journal | author=Holopainen JM, Saarikoski J, Kinnunen PK, Järvelä I |title=Elevated lysosomal pH in neuronal ceroid lipofuscinoses (NCLs). |journal=Eur. J. Biochem. |volume=268 |issue= 22 |pages= 5851–6 |year= 2001 |pmid= 11722572 |doi=
*cite journal | author=Isosomppi J, Vesa J, Jalanko A, Peltonen L |title=Lysosomal localization of the neuronal ceroid lipofuscinosis CLN5 protein. |journal=Hum. Mol. Genet. |volume=11 |issue= 8 |pages= 885–91 |year= 2003 |pmid= 11971870 |doi=
*cite journal | author=Vesa J, Chin MH, Oelgeschläger K, "et al." |title=Neuronal ceroid lipofuscinoses are connected at molecular level: interaction of CLN5 protein with CLN2 and CLN3. |journal=Mol. Biol. Cell |volume=13 |issue= 7 |pages= 2410–20 |year= 2003 |pmid= 12134079 |doi= 10.1091/mbc.E02-01-0031
*cite journal | author=Pineda-Trujillo N, Cornejo W, Carrizosa J, "et al." |title=A CLN5 mutation causing an atypical neuronal ceroid lipofuscinosis of juvenile onset. |journal=Neurology |volume=64 |issue= 4 |pages= 740–2 |year= 2005 |pmid= 15728307 |doi= 10.1212/01.WNL.0000151974.44980.F1
*cite journal | author=Bessa C, Teixeira CA, Mangas M, "et al." |title=Two novel CLN5 mutations in a Portuguese patient with vLINCL: insights into molecular mechanisms of CLN5 deficiency. |journal=Mol. Genet. Metab. |volume=89 |issue= 3 |pages= 245–53 |year= 2006 |pmid= 16814585 |doi= 10.1016/j.ymgme.2006.04.010
*cite journal | author=Ewing RM, Chu P, Elisma F, "et al." |title=Large-scale mapping of human protein-protein interactions by mass spectrometry. |journal=Mol. Syst. Biol. |volume=3 |issue= |pages= 89 |year= 2007 |pmid= 17353931 |doi= 10.1038/msb4100134
*cite journal | author=Cannelli N, Nardocci N, Cassandrini D, "et al." |title=Revelation of a novel CLN5 mutation in early juvenile neuronal ceroid lipofuscinosis. |journal=Neuropediatrics |volume=38 |issue= 1 |pages= 46–9 |year= 2007 |pmid= 17607606 |doi= 10.1055/s-2007-981449

PBB_Controls
update_page = yes
require_manual_inspection = no
update_protein_box = yes
update_summary = yes
update_citations = yes


Wikimedia Foundation. 2010.

Игры ⚽ Поможем сделать НИР

Look at other dictionaries:

  • Neuronal ceroid lipofuscinosis — Classification and external resources ICD 10 E75.4 ICD 9 330.1 …   Wikipedia

  • Lysosomale Speicherkrankheit — Lysosomale Speicherkrankheiten (LSK) sind eine Gruppe von etwa 45 genetisch bedingten Stoffwechselerkrankungen, die durch Fehlfunktionen im Lysosom ausgelöst werden. Die Erkrankungen sind monogenetisch.[1] In der angelsächsischen Fachliteratur… …   Deutsch Wikipedia

  • Lysosomale Speicherkrankheiten — (LSK) sind eine Gruppe von etwa 45 genetisch bedingten Stoffwechselerkrankungen, die durch Fehlfunktionen im Lysosom ausgelöst werden. Die Erkrankungen sind monogenetisch.[1] In der angelsächsischen Fachliteratur wird meist der Begriff Lysosomal… …   Deutsch Wikipedia

  • Metabolism — Cell metabolism redirects here. For the journal, see Cell Metabolism. Structure of adenosine triphosphate, a central intermediate in energy metabolism Metabolism (from Greek: μεταβολή metabolē , change or Greek: μεταβολισμός metabolismos,… …   Wikipedia

  • Hexosaminidase — β N acetylhexosaminidase Hexosaminidase A (Hex A) Identifiers EC number 3.2.1.52 …   Wikipedia

  • CLN3 — Ceroid lipofuscinosis, neuronal 3 Identifiers Symbols CLN3; BTS; JNCL; MGC102840 External IDs …   Wikipedia

  • Arylsulfatase A — PDB rendering based on 1auk …   Wikipedia

  • Ceramidase — is an enzyme which cleaves fatty acids from ceramide, producing sphingosine (SPH) which in turn is phosphorylated by a sphingosine kinase to form sphingosine 1 phosphate (S1P).[1] Contents 1 Function 2 Clinical significance …   Wikipedia

  • Ceramide glucosyltransferase — (or glucosylceramide synthase) is a glucosyltransferase enzyme involved in the production of glucosylceramide. It is classified under EC 2.4.1.80. It is inhibited by miglustat. See also Glucosylceramide External links MeSH… …   Wikipedia

  • Tripeptidyl peptidase I — Tripeptidyl peptidase I, also known as TPP1, is a human gene.cite web | title = Entrez Gene: TPP1 tripeptidyl peptidase I| url = http://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene Cmd=ShowDetailView TermToSearch=1200| accessdate = ] PBB Summary… …   Wikipedia

Share the article and excerpts

Direct link
Do a right-click on the link above
and select “Copy Link”